PERSISTENCE WITH ANTI-OSTEOPOROTIC THERAPY IN PATIENTS WITH RHEUMATIC DISEASE

被引：0
|
作者：
Mizuki, S. [1 ]
Kushimoto, K. [1 ]
Yamasaki, H. [1 ]
Yoshida, K. [1 ]
Oryoji, K. [1 ]
Kamada, K. [1 ]
Yokota, E. [1 ]
机构：
[1] Matsuyama Red Cross Hosp, Ctr Rheumat Dis, Matsuyama, Ehime, Japan
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2016年 / 75卷
关键词：
D O I：
10.1136/annrheumdis-2016-eular.4191
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
THU0486
引用
收藏
页码：367 / 367
页数：1
相关论文
共 50 条
  • [31] USE OF QUALITATIVE RESEARCH TO IDENTIFY DIFFERENCES BETWEEN DETERMINANTS OF ADHERENCE AND PERSISTENCE FOR ANTI-OSTEOPOROTIC TREATMENTS
    Alegre, Patricia
    Arnould, Benoit
    Marrel, Alexia
    OSTEOPOROSIS INTERNATIONAL, 2011, 22 : 349 - 350
  • [32] HISTOMORPHOMETRIC STUDY IN OSTEOPOROTIC PATIENTS WITH NEW FRACTURES AFTER LONG TERM ANTI-OSTEOPOROTIC TREATMENT
    Batteux, B.
    Sejourne, A.
    Cohen-Solal, M.
    Goeb, V.
    Fardellone, P.
    OSTEOPOROSIS INTERNATIONAL, 2016, 27 : S392 - S392
  • [33] Denosumab is effective toward glucocorticoid-induced osteoporosis patients complicated with rheumatic diseases regardless of prior anti-osteoporotic drugs
    Naoki Iwamoto
    Momoko Okamoto
    Sosuke Tsuji
    Yushiro Endo
    Ayuko Takatani
    Toshimasa Shimizu
    Masataka Umeda
    Shoichi Fukui
    Remi Sumiyoshi
    Takashi Igawa
    Tomohiro Koga
    Shin-ya Kawashiri
    Toshiyuki Aramaki
    Kunihiro Ichinose
    Mami Tamai
    Hideki Nakamura
    Tomoki Origuchi
    Katsumi Eguchi
    Yukitaka Ueki
    Atsushi Kawakami
    Journal of Bone and Mineral Metabolism, 2019, 37 : 554 - 562
  • [34] Denosumab is effective toward glucocorticoid-induced osteoporosis patients complicated with rheumatic diseases regardless of prior anti-osteoporotic drugs
    Iwamoto, Naoki
    Okamoto, Momoko
    Tsuji, Sosuke
    Endo, Yushiro
    Takatani, Ayuko
    Shimizu, Toshimasa
    Umeda, Masataka
    Fukui, Shoichi
    Sumiyoshi, Remi
    Igawa, Takashi
    Koga, Tomohiro
    Kawashiri, Shin-ya
    Aramaki, Toshiyuki
    Ichinose, Kunihiro
    Tamai, Mami
    Nakamura, Hideki
    Origuchi, Tomoki
    Eguchi, Katsumi
    Ueki, Yukitaka
    Kawakami, Atsushi
    JOURNAL OF BONE AND MINERAL METABOLISM, 2019, 37 (03) : 554 - 562
  • [35] Impact of Glucocorticoid Dosing and Anti-Osteoporotic Treatment on Bone Health in Patients with Inflammatory Rheumatic Musculoskeletal Diseases: A Longitudinal Cohort Study
    Adami, Giovanni
    Fassio, Angelo
    Bertelle, Davide
    Benini, Camilla
    Gatti, Davide
    Rossini, Maurizio
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 4531 - 4533
  • [36] Anabolic Peptide-Enriched Stealth Nanoliposomes for Effective Anti-Osteoporotic Therapy
    Salave, Sagar
    Rana, Dhwani
    Kumar, Hemant
    Kommineni, Nagavendra
    Benival, Derajram
    PHARMACEUTICS, 2022, 14 (11)
  • [37] Are anti-osteoporotic agents the solution for treating osteoarthritis?
    Dere, W.
    OSTEOPOROSIS INTERNATIONAL, 2007, 18 : S2 - S3
  • [38] CYTOKINES AND ESTROGEN IN BONE - ANTI-OSTEOPOROTIC EFFECTS
    HOROWITZ, MC
    SCIENCE, 1993, 260 (5108) : 626 - 627
  • [39] Anti-osteoporotic treatment of a polymedicated patient (II)
    Alehyan Dabbakh, Amina
    ARS PHARMACEUTICA, 2010, 51 : 116 - 118
  • [40] Anti-osteoporotic treatment of a polymedicated patient (I)
    Alehyan Dabbakh, Amina
    ARS PHARMACEUTICA, 2010, 51 : 112 - 115
12345